LinusBio

We aspire to transform the way complex health conditions are diagnosed and treated.
#Autism #ASD #ALS

[KMOV @KMOV]

A new test that analyzes just a strand of hair is being hailed as a game-changer in the early detection of autism. https://t.co/15yCv052gD

[LinusBio @linusbio]

The Washington Post recently covered the national conversation around large-scale autism research initiatives. LinusBio's CEO, Dr. Manish Arora, was invited to contribute his perspective.
Read the full story ➡️ https://t.co/HnL5OYPMoW

[LinusBio @linusbio]

Today, on World Autism Awareness Day, LinusBio is proud to announce our partnership with The BRAIN Foundation to advance biomarker-supported autism diagnosis and early intervention.
Learn more➡️ https://t.co/YUwHUAoKqz

[LinusBio @linusbio]

We’re extremely proud to announce the launch of ClearStrand-ASD –a ground-breaking, first-of-its kind biomarker test that provides biochemical insights about autism as early as one month of age—using just a single strand of hair!
https://t.co/MCkAvEFX8K

[Inside Precision Medicine @Inside_PM]

With One Strand of Hair, @linusbio Can Guide Autism Diagnosis and Treatment

By decoding complex metabolite patterns, the test can rule-out #autism in children aged one to 36 months, a major drop from the current average of four years. @GrinsteinJ
https://t.co/VZDJkoaDMR

[LinusBio @linusbio]

"Our genes are static, whereas our exposome changes all the time. So how do we map something that is constantly dynamic?"
LinusBio's CEO, Dr. Manish Arora, talks with Karen Jagoda about harnessing the exposome to generate novel biomarkers.
https://t.co/gXKZjnGgTZ

[LinusBio @linusbio]

Innovative. Transformative. Pioneering.
Big news is on the horizon; stay tuned!
#ASD #Biomarker

[Genetic Engineering & Biotechnology News @GENbio]

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?

The time dimension is where the secrets of the CNS are hidden, says @linusbio CEO Dr. Manish Arora. Read more: https://t.co/Wgwa1h2a0O

[LinusBio @linusbio]

Read more➡️
https://t.co/p74swWvH76

[LinusBio @linusbio]

The time dimension is where the secrets of the CNS are hidden.
Dr. Manish Arora's op-ed on @GENbio highlights the need to rethink our approach to neuroscience drug development.
#Neuroscience #DrugDevelopment #Innovation #CNS #Biotech

[LinusBio @linusbio]

We are proud to be featured on @FiercePharma 2023 #Fierce15 list of medical technology companies. Read the full article here ➡️ https://t.co/SyXBjvQ2tu
#Medtech #PrecisionMedicine

[LinusBio @linusbio]

Thrilled to be part of BioSpace's prestigious NextGen Bio Class of 2024! Recognized among the top life sciences startups to watch, we're excited to contribute to innovation and make an impact in the industry. #NextGen2024

[BioSpace @biospace]

BioSpace unveils the NextGen Bio Class of 2024. Dive into the future with our tenth annual list life sciences top most promising startups.
https://t.co/uPiMbDr2Fp
#NextGen2024 #BioSpace #Startups

[LinusBio @linusbio]

📸 Captured a moment of #AutismInnovation at the #SDBP2023 Annual Meeting in Minneapolis, MN, which concluded today. 🧩
Our team was thrilled to be part of this journey towards Early Answers for Autism.
A big thank you to all the attendees who stopped by and to @SDBPeds.

[LinusBio @linusbio]

"Early Answers for Autism Are on the Way!" 🧩 Join us at the #SDBP2023 Annual Meeting, hosted by @SDBPeds .
📅 September 7-11, Minneapolis, MN. If you're attending, be sure to drop by and meet our team. Let's drive #AutismInnovation together!

[LinusBio @linusbio]

From baby teeth to a strand of hair: learn about our autism biomarker journey.

Explore our peer-reviewed publications>> https://t.co/4ZyYL51Otf

#autism #research #exposomesequencing #diagnostictests #treatments

[Daniel S. Levine @dslevine]

Manish Arora @LinusBio discusses the exposome, how the company’s test for autism works, and how this opens the potential for early intervention. @globalgenes #RARECast

https://t.co/ws6nxVxrxR

[LinusBio @linusbio]

Exciting news! We are thrilled to announce we've successfully secured our A2 funding series, fueling international partnerships and production scale.
#milestone #fundinground
Read full details here ➡️ https://t.co/34ilKl1Ivs

[LinusBio @linusbio]

LinusBio is taking the presentation stage at the 2023 BIO International Convention in Boston, June 5-8. We are thrilled to showcase our company's innovation in the field of precision exposome medicine.
Click to send us a meeting request #BIO2023

https://t.co/3BflYzGzO7

[LinusBio @linusbio]

LinusBio is excited to present our innovation at #BioNJ’s BioPartnering Conference, April 18 at The Palace, Somerset Park, NJ. Come meet with us! #BioP2023 #PartneringForPossibility https://t.co/8LT9mCUGFu

[LinusBio @linusbio]

Thrilled to share that our study, Elemental Dynamics in Hair Accurately Predict Future Autism Spectrum Disorder Diagnosis, has been selected for @NIEHS 'papers of the month'! Congrats to our amazing team and collaborators for this achievement! #autism
https://t.co/EjRV1jwghX

[LinusBio @linusbio]

Excited to be included in @OmdenaAI's "46 Groundbreaking AI-Enabled Biotech Companies of 2023" ➡️➡️

[Omdena #AI @OmdenaAI]

46 Groundbreaking AI-Enabled Biotech Companies of 2023

https://t.co/94EjlfB5uc